8-K Announcements
6Material company update
May 15, 2026·SEC
Material company update
May 14, 2026·SEC
Material company update
Mar 20, 2026·SEC
Aveanna Healthcare Holdings Inc.(AVAH)Earnings, Financials & Key Ratios
AVAH•NASDAQ
7.4× P/E·Price updated Jun 19, 2026
AboutAveanna Healthcare Holdings Inc., a diversified home care platform company, provides private duty nursing (PDN), adult home health and hospice, home-based pediatric therapy, and enteral nutrition services in the United States. Its patient- centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals. The company operates through three segments: Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS). The PDS segment offers PDN services, which include in-home skilled nursing services to medically fragile children; nursing services in school settings in which its caregivers accompany patients to school; services to patients in its pediatric day healthcare centers; and employer of record support and personal care services, as well as in-clinic and home-based pediatric therapy services, such as physical, occupational, and speech services. The HHH segment provides home health services, including in-home skilled nursing services; physical, occupational, and speech therapy services; and medical social and aide services, as well as hospice services for patients and their families when a life-limiting illness no longer responds to cure-oriented treatments. The MS segment offers enteral nutrition supplies and other products to adults and children delivered on a periodic or as-needed basis. The company was incorporated in 2016 and is headquartered in Atlanta, Georgia.Show more
- Revenue$2.43B+20.2%
- EBITDA$289M+69.1%
- Net Income$225M+2159.1%
- EPS (Diluted)1.05+1951.9%
- Gross Margin33.09%+5.4%
- EBITDA Margin11.88%+40.7%
- Operating Margin10.91%+58.0%
- Net Margin9.25%+1813.3%
- ROE621.89%
AVAH Key Insights
Aveanna Healthcare Holdings Inc. (AVAH) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Excellent 3Y average ROE of 621.9%
- ✓Strong 5Y sales CAGR of 10.2%
- ✓Efficient asset utilization: 1.2x turnover
✗Weaknesses
- ✗High debt to equity ratio of 6.9x
- ✗Shares diluted 11.4% in last year
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
Get notified when AVAH posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
AVAH Price & Volume
Aveanna Healthcare Holdings Inc. (AVAH) stock price & volume — 10-year historical chart
Loading chart...
AVAH Growth Metrics
Aveanna Healthcare Holdings Inc. (AVAH) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-
5 Years10.23%
3 Years10.82%
TTM20.49%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM4710.41%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM7579.11%
Return on Capital
10 Years-0.55%
5 Years-1.97%
3 Years10.08%
Last Year18.54%
AVAH Recent Earnings
Aveanna Healthcare Holdings Inc. (AVAH) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 9/12 qtrs (75%)●Beat Revenue 11/12 qtrs (92%)
Q2 2026Latest
May 14, 2026Metric
Actual
Est
EPS
$0.18+38.5%
$0.13
Rev
$648M+5.7%
$613M
Q2 2026
Mar 19, 2026Metric
Actual
Est
EPS
$0.17+10.5%
$0.15
Rev
$662M+3.0%
$643M
Q4 2025
Nov 6, 2025Metric
Actual
Est
EPS
$0.15+87.5%
$0.08
Rev
$622M-4.2%
$649M
Q3 2025
Aug 7, 2025Metric
Actual
Est
EPS
$0.18+350.0%
$0.04
Rev
$590M+9.1%
$540M
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 14, 2026 | $0.18vs $0.13+38.5% | $648Mvs $613M+5.7% |
| Q2 2026 | Mar 19, 2026 | $0.17vs $0.15+10.5% | $662Mvs $643M+3.0% |
| Q4 2025 | Nov 6, 2025 | $0.15vs $0.08+87.5% | $622Mvs $649M-4.2% |
| Q3 2025 | Aug 7, 2025 | $0.18vs $0.04+350.0% | $590Mvs $540M+9.1% |
Based on last 12 quarters of dataView full earnings history →
AVAH Peer Comparison
Aveanna Healthcare Holdings Inc. (AVAH) competitors in Home-based care services — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 PNTG | 1.16B | 33.44 | 39.81 | 36.31% | 2.96% | 8.42% | 1.21 | |
 ADUS | 1.76B | 94.23 | 18.09 | 23.21% | 6.89% | 9.34% | 0.19 | |
 HCSG | 1.64B | 22.94 | 28.32 | 7.08% | 3.21% | 11.83% | 0.05 | |
 ENSG | 8.98B | 153.65 | 26.31 | 18.72% | 6.89% | 16.61% | 1.86 | |
 MMS | 2.93B | 55.74 | 10.12 | 2.36% | 7.02% | 21.75% | 0.86 | |
 OPCH | 3.44B | 21.99 | 17.32 | 13.03% | 3.64% | 15.28% | ||
 BFAM | 3.52B | 64.32 | 19.14 | 9.22% | 7.61% | 17.08% | 1.31 | |
 UNH | 363.94B | 400.96 | 30.31 | 11.81% | 2.68% | 11.54% | 0.77 |
Compare AVAH vs Peers
Aveanna Healthcare Holdings Inc. (AVAH) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
AVAH Income Statement
Aveanna Healthcare Holdings Inc. (AVAH) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Metric | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Jan'26 | TTM |
|---|---|---|---|---|---|---|---|---|---|
Sales/Revenue | 1.25B | 1.38B | 1.5B | 1.68B | 1.79B | 1.9B | 2.02B | 2.43B | 2.52B |
Revenue Growth % | - | 10.4% | 8.02% | 12.27% | 6.49% | 6.02% | 6.82% | 20.19% | 20.49% |
Cost of Goods Sold | 859.35M | 964.81M | 1.04B | 1.14B | 1.23B | 1.3B | 1.39B | 1.63B | 1.7B |
COGS % of Revenue | 68.55% | 69.71% | 69.6% | 67.69% | 69.05% | 68.58% | 68.61% | 66.91% | - |
Gross Profit | 394.32M▲ 0% | 419.25M▲ 6.3% | 454.51M▲ 8.4% | 542.4M▲ 19.3% | 553.23M▲ 2.0% | 595.43M▲ 7.6% | 635.54M▲ 6.7% | 805.15M▲ 26.7% | 823.98M▲ 0% |
Gross Margin % | 31.45% | 30.29% | 30.4% | 32.31% | 30.95% | 31.42% | 31.39% | 33.09% | 32.67% |
Gross Profit Growth % | - | 6.32% | 8.41% | 19.34% | 2% | 7.63% | 6.74% | 26.69% | - |
Operating Expenses | 339.71M | 380.3M | 458M | 578.51M | 1.2B | 587.36M | 495.75M | 539.77M | 534.46M |
OpEx % of Revenue | 27.1% | 27.48% | 30.63% | 34.46% | 66.88% | 30.99% | 24.49% | 22.18% | - |
Selling, General & Admin | 321.84M | 341M | 354.77M | 419.64M | 483.95M | 464.74M | 470.47M | 526.74M | 524.68M |
SG&A % of Revenue | 25.67% | 24.64% | 23.73% | 25% | 27.07% | 24.52% | 23.24% | 21.65% | - |
Research & Development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
R&D % of Revenue | - | - | - | - | - | - | - | - | - |
Other Operating Expenses | -13.74M | 39.3M | 103.23M | 158.88M | 711.56M | 122.62M | 25.28M | 13.04M | 2.42M |
Operating Income | 39.03M▲ 0% | 38.95M▼ 0.2% | -3.49M▼ 109.0% | -36.11M▼ 935.6% | -642.28M▼ 1678.6% | 8.07M▲ 101.3% | 139.79M▲ 1631.8% | 265.38M▲ 89.8% | 289.52M▲ 0% |
Operating Margin % | 3.11% | 2.81% | -0.23% | -2.15% | -35.93% | 0.43% | 6.9% | 10.91% | 11.48% |
Operating Income Growth % | - | -0.2% | -108.95% | -935.59% | -1678.62% | 101.26% | 1631.75% | 89.85% | - |
EBITDA | 50.97M | 65.97M | 26.74M | -722K | -603.46M | 38.17M | 170.95M | 289.15M | 313.99M |
EBITDA Margin % | 4.07% | 4.77% | 1.79% | -0.04% | -33.76% | 2.01% | 8.44% | 11.88% | 12.45% |
EBITDA Growth % | - | 29.42% | -59.47% | -102.7% | -83481.72% | 106.33% | 347.86% | 69.14% | 58.83% |
D&A (Non-Cash Add-back) | 11.94M | 27.01M | 30.22M | 35.39M | 38.82M | 30.1M | 31.16M | 23.77M | 24.47M |
EBIT | 25.88M | 17.27M | 31.25M | -53.34M | -563.87M | 9.07M | 156.21M | 250.8M | 281.9M |
Net Interest Income | -74.95M | -92.09M | -82.64M | -68.68M | -107.04M | -152.92M | -156.1M | -137.25M | -128.55M |
Interest Income | 594K | 207K | 345K | 253K | 679K | 327K | 498K | 2.83M | 4.36M |
Interest Expense | 75.54M | 92.3M | 82.98M | 68.93M | 107.72M | 153.25M | 156.6M | 140.09M | 132.91M |
Other Income/Expense | -88.69M | -113.98M | -48.25M | -77.47M | -21.54M | -147.07M | -134.72M | -158.43M | -147.75M |
Pretax Income | -49.66M▲ 0% | -75.03M▼ 51.1% | -51.73M▲ 31.0% | -113.58M▼ 119.5% | -663.81M▼ 484.5% | -139M▲ 79.1% | 5.07M▲ 103.6% | 106.95M▲ 2008.6% | 141.78M▲ 0% |
Pretax Margin % | -3.96% | -5.42% | -3.46% | -6.77% | -37.13% | -7.33% | 0.25% | 4.4% | 5.62% |
Income Tax | -2.51M | 1.49M | 5.32M | 3.47M | -1.78M | -4.47M | 16M | -118.09M | -119.72M |
Effective Tax Rate % | 5.06% | -1.98% | -10.28% | -3.05% | 0.27% | 3.22% | 315.48% | -110.41% | -84.44% |
Net Income | -47.15M▲ 0% | -76.52M▼ 62.3% | -57.05M▲ 25.4% | -117.04M▼ 105.2% | -662.03M▼ 465.6% | -134.52M▲ 79.7% | -10.93M▲ 91.9% | 225.03M▲ 2159.1% | 261.49M▲ 0% |
Net Margin % | -3.76% | -5.53% | -3.82% | -6.97% | -37.03% | -7.1% | -0.54% | 9.25% | 10.37% |
Net Income Growth % | - | -62.3% | 25.44% | -105.16% | -465.63% | 79.68% | 91.88% | 2159.05% | 4710.41% |
Net Income (Continuing) | -47.15M | -76.52M | -57.05M | -117.04M | -662.03M | -134.52M | -10.93M | 225.03M | 261.49M |
Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EPS (Diluted) | -0.26▲ 0% | -0.41▼ 57.7% | -0.31▲ 24.4% | -0.63▼ 103.2% | -3.57▼ 466.7% | -0.71▲ 80.1% | -0.06▲ 92.0% | 1.05▲ 1951.9% | 1.18▲ 0% |
EPS Growth % | - | -57.69% | 24.39% | -103.23% | -466.67% | 80.11% | 92.01% | 1951.85% | 7579.11% |
EPS (Basic) | -0.26 | -0.41 | -0.31 | -0.63 | -3.57 | -0.71 | -0.06 | 1.10 | - |
Diluted Shares Outstanding | 180.16M | 185.9M | 185.9M | 184.73M | 185.55M | 189.96M | 192.89M | 214.98M | 222.1M |
Basic Shares Outstanding | 180.16M | 185.9M | 185.9M | 184.73M | 185.55M | 189.96M | 192.89M | 203.53M | 214.59M |
Dividend Payout Ratio | - | - | - | - | - | - | - | - | - |
AVAH Balance Sheet
Aveanna Healthcare Holdings Inc. (AVAH) balance sheet — assets, liabilities & shareholders' equity
| Metric | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Jan'26 | TTM |
|---|---|---|---|---|---|---|---|---|---|
Total Current Assets | 214.93M | 186.34M | 340.64M | 279.21M | 269.75M | 314.89M | 392.67M | 560.23M | 575.3M |
Cash & Short-Term Investments | 8M | 3.33M | 137.34M | 30.49M | 19.22M | 43.94M | 84.29M | 193.26M | 189.27M |
Cash Only | 8M | 3.33M | 137.34M | 30.49M | 19.22M | 43.94M | 84.29M | 193.26M | 189.27M |
Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts Receivable | 182.45M | 164.3M | 180.88M | 225.29M | 225.63M | 245.81M | 277.66M | 313.36M | 335.6M |
Days Sales Outstanding | 53.12 | 43.33 | 44.16 | 48.99 | 46.07 | 47.34 | 50.06 | 47.01 | 46.57 |
Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Days Inventory Outstanding | - | - | - | - | - | - | - | - | - |
Other Current Assets | 14.99M | 8.56M | 11.34M | 9.2M | 9.81M | 9.45M | 13.25M | 29.92M | 26.63M |
Total Non-Current Assets | 1.34B | 1.39B | 1.5B | 2.06B | 1.44B | 1.3B | 1.27B | 1.47B | 1.45B |
Property, Plant & Equipment | 27.25M | 80.47M | 78.87M | 83.37M | 77.35M | 70.05M | 58.65M | 55.69M | 53.86M |
Fixed Asset Turnover | 46.00x | 17.20x | 18.96x | 20.14x | 23.11x | 27.06x | 34.52x | 43.69x | 45.58x |
Goodwill | 1.23B | 1.23B | 1.32B | 1.84B | 1.16B | 1.05B | 1.05B | 1.12B | 1.12B |
Intangible Assets | 53.34M | 54.3M | 73.57M | 102.85M | 95.86M | 94.01M | 89.57M | 92.56M | 91.93M |
Long-Term Investments | 21.74M | 0 | 0 | 0 | 0 | 74.81M | 60.63M | 37.51M | 154.44M |
Other Non-Current Assets | 8.27M | 30.35M | 31.62M | 33.36M | 109.11M | 4.67M | 7.33M | 8.21M | 4.35M |
Total Assets | 1.55B▲ 0% | 1.58B▲ 1.8% | 1.84B▲ 16.8% | 2.33B▲ 26.6% | 1.71B▼ 26.7% | 1.61B▼ 5.8% | 1.66B▲ 3.1% | 2.03B▲ 21.8% | 2.02B▲ 0% |
Asset Turnover | 0.81x | 0.88x | 0.81x | 0.72x | 1.04x | 1.17x | 1.22x | 1.20x | 1.32x |
Asset Growth % | - | 1.77% | 16.83% | 26.59% | -26.67% | -5.77% | 3.13% | 21.78% | 60.05% |
Total Current Liabilities | 198.36M | 168.54M | 260.41M | 344.83M | 326.5M | 354.76M | 402.17M | 424.46M | 390.43M |
Accounts Payable | 0 | 66.42M | 56.67M | 52.62M | 44.62M | 30.13M | 36.44M | 31.97M | 34.36M |
Days Payables Outstanding | - | 25.13 | 19.88 | 16.91 | 13.19 | 8.46 | 9.57 | 7.17 | 7.52 |
Short-Term Debt | 9.4M | 10.09M | 12.78M | 13.71M | 15.38M | 168.16M | 183.1M | 29.26M | 193.7M |
Deferred Revenue (Current) | -37.99M | 0 | 29.44M | 0 | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 113.97M | 20.74M | 54.89M | 174.37M | 181.26M | 42.24M | 38.65M | 363.23M | 85.01M |
Current Ratio | 1.08x | 1.11x | 1.31x | 0.81x | 0.83x | 0.89x | 0.98x | 1.32x | 1.47x |
Quick Ratio | 1.08x | 1.11x | 1.31x | 0.81x | 0.83x | 0.89x | 0.98x | 1.32x | 1.47x |
Cash Conversion Cycle | - | - | - | - | - | - | - | - | 39.05 |
Total Non-Current Liabilities | 1.01B | 1.14B | 1.32B | 1.35B | 1.39B | 1.39B | 1.38B | 1.41B | 1.39B |
Long-Term Debt | 954.73M | 1.02B | 1.16B | 1.23B | 1.28B | 1.28B | 1.27B | 1.29B | 1.28B |
Capital Lease Obligations | 0 | 41.22M | 40.25M | 44.68M | 45.82M | 39.82M | 31.72M | 27.41M | 106.34M |
Deferred Tax Liabilities | 1.75M | 1.75M | 27.41M | 3.05M | 3.84M | 4.86M | 5.89M | 13.34M | 26.34M |
Other Non-Current Liabilities | 52.86M | 78.42M | 85.28M | 77.34M | 58.69M | 64.64M | 74.05M | 78.67M | 82.24M |
Total Liabilities | 1.21B | 1.31B | 1.58B | 1.7B | 1.72B | 1.74B | 1.79B | 1.83B | 1.78B |
Total Debt | 952.44M | 1.08B | 1.23B | 1.3B | 1.36B | 1.5B | 1.5B | 1.34B | 1.5B |
Net Debt | 944.44M | 1.08B | 1.09B | 1.27B | 1.34B | 1.46B | 1.42B | 1.15B | 1.31B |
Debt / Equity | 2.76x | 3.98x | 4.60x | 2.04x | - | - | - | 6.91x | 6.26x |
Debt / EBITDA | 18.69x | 16.37x | 45.94x | - | - | 39.28x | 8.79x | 4.65x | 4.78x |
Net Debt / EBITDA | 18.53x | 16.32x | 40.81x | - | - | 38.13x | 8.29x | 3.98x | 4.18x |
Interest Coverage | 0.34x | 0.19x | 0.38x | -0.77x | -5.23x | 0.06x | 1.00x | 1.79x | 2.12x |
Total Equity | 344.99M▲ 0% | 270.94M▼ 21.5% | 267.17M▼ 1.4% | 637.95M▲ 138.8% | -4.17M▼ 100.7% | -127.44M▼ 2952.3% | -122.09M▲ 4.2% | 194.46M▲ 259.3% | 240.05M▲ 0% |
Equity Growth % | - | -21.46% | -1.39% | 138.78% | -100.65% | -2952.34% | 4.19% | 259.28% | 799.38% |
Book Value per Share | 1.91 | 1.46 | 1.44 | 3.45 | -0.02 | -0.67 | -0.63 | 0.90 | 1.08 |
Total Shareholders' Equity | 344.99M | 270.94M | 267.17M | 637.95M | -4.17M | -127.44M | -122.09M | 194.46M | 240.05M |
Common Stock | 66K | 1.37M | 1.42M | 1.85M | 1.89M | 1.91M | 1.93M | 2.11M | 2.17M |
Retained Earnings | -323.83M | -400.58M | -457.63M | -574.68M | -1.24B | -1.37B | -1.38B | -1.16B | -1.12B |
Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accumulated OCI | 0 | 0 | 0 | 0 | 0 | 2.13M | 1.46M | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
AVAH Cash Flow Statement
Aveanna Healthcare Holdings Inc. (AVAH) cash flow — operating, investing & free cash flow history
| Metric | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Jan'26 | TTM |
|---|---|---|---|---|---|---|---|---|---|
Cash from Operations | 21.6M | -8.71M | 116.62M | -11.35M | -48.4M | 22.67M | 32.64M | 122.24M | 138.84M |
Operating CF Margin % | 1.72% | -0.63% | 7.8% | -0.68% | -2.71% | 1.2% | 1.61% | 5.02% | - |
Operating CF Growth % | - | -140.35% | 1438.28% | -109.73% | -326.45% | 146.84% | 43.95% | 274.54% | 3184.9% |
Net Income | -47.15M | -76.52M | -57.05M | -117.04M | -662.03M | -134.52M | -10.93M | 225.03M | 261.49M |
Depreciation & Amortization | 11.94M | 27.01M | 30.22M | 35.39M | 38.82M | 30.1M | 31.16M | 28.22M | 705K |
Stock-Based Compensation | 2.12M | 1.95M | 3.27M | 14.43M | 15.89M | 13.16M | 17.46M | 0 | -11M |
Deferred Taxes | -3.63M | -919K | -6.42M | 1.31M | -115K | 1.01M | 1.03M | -143.03M | -612K |
Other Non-Cash Items | 23.56M | 26.7M | 90.06M | 125.89M | 601.26M | 136.32M | 23.87M | 64.67M | -106.86M |
Working Capital Changes | 34.76M | 13.06M | 56.54M | -71.33M | -42.22M | -23.4M | -29.97M | -52.66M | -4.9M |
Change in Receivables | -7.96M | 3.34M | 8.56M | -8.81M | -3.23M | -15.32M | -28.64M | -30.22M | 10.31M |
Change in Inventory | 15.4M | -13.2M | 0 | -27.06M | 0 | 0 | 0 | 0 | 0 |
Change in Payables | 21.51M | 19.29M | -6.81M | -11.7M | -3.92M | -13.92M | 6.45M | -6.23M | 8.52M |
Cash from Investing | -229.55M | -17.82M | -193.54M | -681.83M | -25.29M | -8.79M | -6.32M | -22.3M | -24.51M |
Capital Expenditures | -19.58M | -16.64M | -15.24M | -15.95M | -12.01M | -6.12M | -6.32M | -7.45M | -2.21M |
CapEx % of Revenue | 1.56% | 1.2% | 1.02% | 0.95% | 0.67% | 0.32% | 0.31% | 0.31% | 0.09% |
Acquisitions | -209.97M | -1.19M | -178.31M | -666.91M | -1.55M | 0 | 0 | -14.85M | 0 |
Investments | - | - | - | - | - | - | - | - | - |
Other Investing | 0 | 0 | 0 | 0 | -11.27M | -2.68M | 0 | 0 | -22.3M |
Cash from Financing | 204.15M | 21.86M | 210.94M | 586.33M | 62.42M | 10.85M | 14.03M | 9.03M | 3.45M |
Debt Issued (Net) | 149.73M | 68.94M | 136.69M | 161.59M | 60.15M | -5.73M | -2.36M | -3.76M | -655K |
Equity Issued (Net) | 54.42M | 0 | 50M | 477.69M | 4.01M | 945K | 3.09M | 6.52M | -1.52M |
Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Financing | 0 | -47.07M | 24.25M | -52.95M | -1.74M | 15.63M | 13.3M | 6.27M | 5.63M |
Net Change in Cash | -3.8M▲ 0% | -4.67M▼ 23.1% | 134.02M▲ 2967.3% | -106.86M▼ 179.7% | -11.27M▲ 89.5% | 24.73M▲ 319.3% | 40.35M▲ 63.2% | 108.97M▲ 170.1% | 117.78M▲ 0% |
Free Cash Flow | 2.02M▲ 0% | -25.35M▼ 1356.9% | 101.38M▲ 499.9% | -27.3M▼ 126.9% | -60.41M▼ 121.3% | 16.56M▲ 127.4% | 26.32M▲ 59.0% | 114.79M▲ 336.2% | 136.63M▲ 0% |
FCF Margin % | 0.16% | -1.83% | 6.78% | -1.63% | -3.38% | 0.87% | 1.3% | 4.72% | 5.42% |
FCF Growth % | - | -1356.87% | 499.91% | -126.93% | -121.3% | 127.4% | 58.96% | 336.17% | 377.42% |
FCF per Share | 0.01 | -0.14 | 0.55 | -0.15 | -0.33 | 0.09 | 0.14 | 0.53 | 0.62 |
FCF Conversion (FCF/Net Income) | -0.46x | 0.11x | -2.04x | 0.10x | 0.07x | -0.17x | -2.99x | 0.54x | 0.52x |
Interest Paid | 62.77M | 92.81M | 73.05M | 58.96M | 102.53M | 137.85M | 152.51M | 0 | 0 |
Taxes Paid | 3.15M | 1.55M | 2.17M | 5.28M | 1.59M | 1.14M | 5.71M | 0 | 0 |
AVAH Key Ratios
Aveanna Healthcare Holdings Inc. (AVAH) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|
Return on Equity (ROE) | -24.85% | -21.2% | -25.86% | -208.92% | - | - | 621.89% | 241.47% |
Return on Invested Capital (ROIC) | 2.22% | -0.19% | -1.66% | -29.75% | 0.46% | 7.99% | 15.08% | 15.83% |
Gross Margin | 30.29% | 30.4% | 32.31% | 30.95% | 31.42% | 31.39% | 33.09% | 32.67% |
Net Margin | -5.53% | -3.82% | -6.97% | -37.03% | -7.1% | -0.54% | 9.25% | 10.37% |
Debt / Equity | 3.98x | 4.60x | 2.04x | - | - | - | 6.91x | 6.26x |
Interest Coverage | 0.19x | 0.38x | -0.77x | -5.23x | 0.06x | 1.00x | 1.79x | 2.12x |
FCF Conversion | 0.11x | -2.04x | 0.10x | 0.07x | -0.17x | -2.99x | 0.54x | 0.52x |
Revenue Growth | 10.4% | 8.02% | 12.27% | 6.49% | 6.02% | 6.82% | 20.19% | 20.49% |
Related:AVAH Dividend History·AVAH Revenue History·AVAH Price History·AVAH P/E History·AVAH Financial Ratios·AVAH Institutional Holders
AVAH SEC Filings & Documents
Aveanna Healthcare Holdings Inc. (AVAH) SEC filings — annual & quarterly reports (10-K, 10-Q)
AVAH Frequently Asked Questions
Aveanna Healthcare Holdings Inc. (AVAH) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Aveanna Healthcare Holdings Inc. (AVAH) reported $2.52B in revenue for fiscal year 2025. This represents a 101% increase from $1.25B in 2018.
Aveanna Healthcare Holdings Inc. (AVAH) grew revenue by 20.2% over the past year. This is strong growth.
Yes, Aveanna Healthcare Holdings Inc. (AVAH) is profitable, generating $261.5M in net income for fiscal year 2025 (9.2% net margin).
Dividend & Returns
Aveanna Healthcare Holdings Inc. (AVAH) has a return on equity (ROE) of 621.9%. This is excellent, indicating efficient use of shareholder capital.
Aveanna Healthcare Holdings Inc. (AVAH) generated $136.6M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.